tiprankstipranks
Trending News
More News >
Unilever plc (UL)
NYSE:UL
Advertisement

Unilever (UL) AI Stock Analysis

Compare
2,262 Followers

Top Page

UL

Unilever

(NYSE:UL)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 4o)
Rating:71Outperform
Price Target:
$68.00
▲(14.71% Upside)
Unilever's overall stock score is driven by strong financial performance and positive earnings call insights, particularly in developed markets and strategic growth areas. However, technical analysis and valuation present a more cautious outlook, with mixed signals and moderate attractiveness.

Unilever (UL) vs. SPDR S&P 500 ETF (SPY)

Unilever Business Overview & Revenue Model

Company DescriptionUnilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Personal Care, Foods & Refreshment, and Home Care segments. The Beauty & Personal Care segment provides skin care and hair care products, deodorants, and skin cleansing products. The Foods & Refreshment segment offers ice cream, soups, bouillons, seasonings, mayonnaise, ketchups, and tea categories. The Home Care segment provides fabric solutions and various cleaning products. The company offers its products under the Domestos, OMO, Seventh Generation, Ben & Jerry's, Knorr, Magnum, Wall's, Bango, the Vegetarian Butcher, Axe, Cif, Comfort, Dove, Lifebuoy, Lux, Rexona, Sunsilk, Equilibra, OLLY, Liquid I.V., SmartyPants, Onnit, Hellmann's, and Vaseline brands. Unilever PLC was incorporated in 1894 and is headquartered in London, the United Kingdom.
How the Company Makes MoneyUnilever generates revenue through the sale of its diverse range of consumer products across different segments. The company operates a multi-channel distribution strategy, including traditional retail, e-commerce, and direct-to-consumer platforms, allowing it to reach a wide customer base. Key revenue streams include personal care products, which account for a significant portion of sales, followed by food and refreshments, and home care products. Unilever's significant partnerships with retailers, both physical and online, enhance its market presence and accessibility. Additionally, the company invests in marketing and innovation to drive brand loyalty and expand its product offerings, further contributing to its earnings.

Unilever Key Performance Indicators (KPIs)

Any
Any
Sales Growth by Segment
Sales Growth by Segment
Analyzes sales increases in various product segments, highlighting areas of strong demand and potential for future expansion.
Chart InsightsUnilever's Beauty and Wellbeing segment shows a steady decline in growth, while Personal Care maintains moderate growth. Home Care and Nutrition segments are experiencing a slowdown, reflecting broader market challenges. The Ice Cream segment, despite recent fluctuations, is on track for a demerger, which could unlock value. The latest earnings call highlights strong performance in developed markets and emerging regions like Asia Pacific, but challenges persist in Latin America and China. The strategic focus on premium segments and brand investments suggests a cautious yet optimistic outlook for sustained growth.
Data provided by:Main Street Data

Unilever Earnings Call Summary

Earnings Call Date:Jul 31, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Feb 05, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a strong performance in developed markets, particularly North America, and promising growth in Asia. However, challenges in Latin America and currency impacts weigh on overall results. The company shows confidence in future growth, particularly with the upcoming Ice Cream demerger and continued investment in innovation.
Q2-2025 Updates
Positive Updates
Strong Developed Markets Performance
Developed markets, which represented 44% of group turnover, continued to perform strongly with first half USG of 4.3%, driven by 3.4% volume and 0.9% price. North America underlying sales grew 5.4% with 3.7% from volume.
Emerging Markets Growth in Asia
Asia Pacific Africa, representing 43% of group turnover, delivered underlying first half sales growth of 3.5% with 1.9% from volume and 1.6% from price. India performed well with 5% USG in second quarter largely driven by volume.
Ice Cream Segment Growth and Demerger
Ice Cream underlying sales grew 5.9%, driven by a 3.8% increase in volume and 2% price growth. The demerger of Ice Cream will take place in mid-November.
Successful Brand Innovations
Strong performances included double-digit growth from Vaseline, Liquid IV, Nutrafol, and Magnum, and high single-digit growth from Dove and Comfort.
Negative Updates
Challenges in Latin America
Latin America, representing 13% of the group turnover, grew 0.5% with a 4.6% decline in volume. Market volume growth turned negative in the second quarter due to economic challenges in Brazil and Mexico.
Volume Decline in Personal Care
Personal Care delivered 4.8% underlying sales growth driven mainly by price (3.3%) with only 1.4% from volume, reflecting subdued macro conditions in Latin America.
Currency Impact on Turnover
Turnover for the first half was EUR 30.1 billion, down 3.2% year-on-year, with a negative currency impact of 4% primarily due to the depreciation of the U.S. dollar versus the euro.
Company Guidance
In the second quarter of 2025, Unilever delivered a robust performance with underlying sales growth of 3.8%, an improvement from the first quarter, driven by a balanced contribution from volume growth of 1.8% and price growth of 2%. For the first half of the year, the company achieved underlying sales growth of 3.4%, with volumes up 1.5% and prices increasing by 1.9%. Notably, developed markets, which constitute 44% of Unilever's turnover, performed strongly with a 4.3% growth, propelled by a 3.4% rise in volumes. North America, in particular, saw underlying sales growth of 5.4%, supported by a 3.7% increase in volume. In emerging markets, the Asia Pacific Africa region reported a 3.5% growth in the first half, with an acceleration to over 5% in the second quarter. Despite challenges in Latin America, where volumes declined by 4.6%, Unilever maintained a competitive edge with ongoing share gains across the region. The company also highlighted its strategic focus on accelerating growth in key categories, including Beauty & Wellbeing, Personal Care, and Ice Cream, noting strong performances in brands like Vaseline, Liquid IV, and Magnum. Unilever remains confident in its full-year outlook, projecting underlying sales growth within the 3% to 5% range and anticipates an improvement in operating margins, driven by volume growth leverage and productivity initiatives.

Unilever Financial Statement Overview

Summary
Unilever's financial performance is robust with steady revenue growth and strong operational efficiency. However, challenges exist in maintaining net profitability and free cash flow levels, and there's a slight decline in ROE.
Income Statement
80
Positive
Unilever's income statement shows a steady revenue growth with a 1.94% increase in 2024 from the previous year. The gross profit margin is strong at approximately 100%, indicating efficient cost management. However, the net profit margin has slightly decreased to 9.45% from 10.88% in 2023, reflecting challenges in maintaining net profitability. EBIT and EBITDA margins remain robust at 15.47% and 21.42%, respectively, demonstrating solid operational efficiency.
Balance Sheet
75
Positive
The balance sheet reflects a moderate debt-to-equity ratio of 1.60, indicating a balanced use of debt financing. The return on equity (ROE) has slightly declined to 28.74% from 35.84% in 2023, suggesting reduced efficiency in generating profit from shareholders' equity. The equity ratio stands at 25.06%, highlighting a stable capital structure with a focus on equity financing.
Cash Flow
70
Positive
Unilever's cash flow statement shows a stable operating cash flow to net income ratio of 1.66, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio has decreased to 1.35 from 1.22 in 2023, which could signal declining free cash flow efficiency. The free cash flow growth rate shows a slight decrease, reflecting challenges in maintaining free cash flow levels.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue60.76B59.60B60.07B52.44B50.72B
Gross Profit60.76B25.18B24.17B22.18B22.04B
EBITDA13.01B11.06B10.71B11.38B11.38B
Net Income5.74B6.49B7.64B6.05B5.58B
Balance Sheet
Total Assets79.75B75.27B77.82B75.09B67.66B
Cash, Cash Equivalents and Short-Term Investments7.63B6.11B5.52B4.50B6.30B
Total Debt30.66B28.59B28.44B29.67B26.77B
Total Liabilities57.20B54.50B56.12B55.35B50.00B
Stockholders Equity19.99B18.10B19.02B17.11B15.27B
Cash Flow
Free Cash Flow7.78B7.92B5.83B6.86B8.20B
Operating Cash Flow9.52B9.43B7.28B7.97B9.06B
Investing Cash Flow-625.00M-2.29B2.45B-3.25B-1.48B
Financing Cash Flow-6.94B-7.19B-8.89B-7.10B-5.80B

Unilever Technical Analysis

Technical Analysis Sentiment
Negative
Last Price59.28
Price Trends
50DMA
61.33
Negative
100DMA
61.45
Negative
200DMA
59.40
Negative
Market Momentum
MACD
-0.61
Positive
RSI
32.88
Neutral
STOCH
3.82
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UL, the sentiment is Negative. The current price of 59.28 is below the 20-day moving average (MA) of 62.28, below the 50-day MA of 61.33, and below the 200-day MA of 59.40, indicating a bearish trend. The MACD of -0.61 indicates Positive momentum. The RSI at 32.88 is Neutral, neither overbought nor oversold. The STOCH value of 3.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for UL.

Unilever Risk Analysis

Unilever disclosed 14 risk factors in its most recent earnings report. Unilever reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Unilever Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$356.92B23.4330.71%2.71%0.29%7.85%
71
Outperform
$145.29B24.2028.36%3.35%-0.30%-14.60%
63
Neutral
$64.33B22.37414.39%2.56%0.05%3.55%
59
Neutral
$31.51B22.3110.65%5.01%-2.15%26.65%
57
Neutral
$40.55B16.85191.19%4.09%-6.89%7.52%
50
Neutral
$31.19B-27.54-29.31%1.62%-8.14%-389.12%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UL
Unilever
59.28
-3.58
-5.70%
CL
Colgate-Palmolive
79.59
-21.94
-21.61%
EL
The Estée Lauder Companies
86.66
-11.20
-11.44%
KMB
Kimberly Clark
122.23
-14.89
-10.86%
PG
Procter & Gamble
152.50
-16.43
-9.73%
KVUE
Kenvue, Inc.
16.42
-5.87
-26.33%

Unilever Corporate Events

Unilever’s Leadership Reinvests in Company Shares
Sep 17, 2025

On September 15, 2025, Unilever PLC reported a transaction involving Esi Bracey, the Chief Growth and Marketing Officer, who reinvested dividends into 912.833 PLC ADR shares at a price of $62.4924 per share, totaling $57,045.12. This transaction, conducted on the New York Stock Exchange, underscores Unilever’s commitment to aligning its leadership’s interests with shareholder value, potentially impacting investor confidence and market perception.

Unilever’s Executive Transactions Reflect Strategic Alignment
Sep 17, 2025

On September 12, 2025, Unilever PLC disclosed several transactions involving its top executives, including CEO Fernando Fernandez, CFO Srinivas Phatak, Chief Growth and Marketing Officer Esi Bracey, and Business Group President Eduardo Campanella. These transactions, conducted on the London and New York Stock Exchanges, involved the accrual of dividend equivalents on unvested share awards, reflecting the company’s ongoing commitment to aligning executive incentives with shareholder interests.

Unilever Announces Directorate Change on September 16, 2025
Sep 16, 2025

On September 16, 2025, Unilever PLC, a leading multinational company in the consumer goods industry, announced a directorate change. This announcement, filed under Form 6-K with the SEC, signifies a strategic shift in the company’s leadership structure, potentially impacting its market positioning and stakeholder relations.

Unilever Appoints Srinivas Phatak as New CFO
Sep 16, 2025

Unilever PLC has appointed Srinivas Phatak as its new Chief Financial Officer, effective immediately, following a comprehensive search process. Srinivas, who previously served as Deputy CFO and Group Controller, was acting CFO since February 2025. His appointment is expected to enhance Unilever’s financial strategy and growth, as noted by CEO Fernando Fernandez, who praised Srinivas’s financial acumen and leadership. This strategic move is anticipated to drive consistent volume growth and margin expansion, benefiting stakeholders and strengthening Unilever’s market position.

Unilever Maintains Stability in Equity Compensation Plans
Sep 15, 2025

On September 15, 2025, Unilever PLC released its six-monthly block listing return, reporting no change in the number of unallotted securities under its share schemes, which include the Unilever Share Plan 2017 and the SHARES Plan. The balance of unallotted securities remains at 6,500,000, indicating stability in the company’s equity compensation plans. This stability may reflect Unilever’s steady approach to managing its equity distribution, which can reassure stakeholders about the company’s financial strategies and market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 20, 2025